Outcomes of open operation for aortoiliac occlusive disease after failed endovascular therapy.

Rachel C Danczyk, Erica L Mitchell, Bryan D Petersen, James Edwards, Timothy K Liem, Gregory J Landry, Gregory L Moneta
{"title":"Outcomes of open operation for aortoiliac occlusive disease after failed endovascular therapy.","authors":"Rachel C Danczyk,&nbsp;Erica L Mitchell,&nbsp;Bryan D Petersen,&nbsp;James Edwards,&nbsp;Timothy K Liem,&nbsp;Gregory J Landry,&nbsp;Gregory L Moneta","doi":"10.1001/archsurg.2012.1649","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To compare patient outcomes of primary open operation for aortoiliac occlusive disease (AIOD) with those of secondary open operations for failed endovascular therapy (ET) of AIOD.</p><p><strong>Design: </strong>A retrospective cohort study was performed analyzing demographic characteristics, comorbidities, and outcomes.</p><p><strong>Setting: </strong>Affiliated Veterans Affairs Hospital from January 1, 1998, through March 31, 2010.</p><p><strong>Patients: </strong>Patients who underwent primary open operation for AIOD or secondary open operation for failed ET of AIOD.</p><p><strong>Main outcome measures: </strong>Overall survival and limb salvage.</p><p><strong>Results: </strong>Primary open operations (n = 153) were 67 aortobifemoral grafts (43.8%), 38 axillobifemoral grafts (24.8%), and 48 femoral-femoral grafts (31.4%). Secondary open operations (n = 35) were 28 aortobifemoral grafts (80.0%), 5 axillobifemoral grafts (14.3%), and 2 femoral-femoral grafts (5.7%). Mean (SD) 5-year survival was 48.2% (5.6%) and 66.8% (10.0%), respectively, for patients undergoing primary vs secondary open surgery for AIOD (P = .01). There were 7 amputations during a mean follow-up of 3 years, all in the primary open surgery group.</p><p><strong>Conclusions: </strong>Despite a higher proportion of coronary artery disease and a 20% conversion of claudication to critical limb ischemia after failed ET for AIOD, survival was longer in patients undergoing secondary vs primary open surgery. Patients who underwent open surgery after failed ET for AIOD did not require amputation. Failed ET for AIOD does not lead to worse outcomes for patients undergoing open surgery for AIOD.</p>","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"841-5"},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.1649","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/archsurg.2012.1649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

Abstract

Objectives: To compare patient outcomes of primary open operation for aortoiliac occlusive disease (AIOD) with those of secondary open operations for failed endovascular therapy (ET) of AIOD.

Design: A retrospective cohort study was performed analyzing demographic characteristics, comorbidities, and outcomes.

Setting: Affiliated Veterans Affairs Hospital from January 1, 1998, through March 31, 2010.

Patients: Patients who underwent primary open operation for AIOD or secondary open operation for failed ET of AIOD.

Main outcome measures: Overall survival and limb salvage.

Results: Primary open operations (n = 153) were 67 aortobifemoral grafts (43.8%), 38 axillobifemoral grafts (24.8%), and 48 femoral-femoral grafts (31.4%). Secondary open operations (n = 35) were 28 aortobifemoral grafts (80.0%), 5 axillobifemoral grafts (14.3%), and 2 femoral-femoral grafts (5.7%). Mean (SD) 5-year survival was 48.2% (5.6%) and 66.8% (10.0%), respectively, for patients undergoing primary vs secondary open surgery for AIOD (P = .01). There were 7 amputations during a mean follow-up of 3 years, all in the primary open surgery group.

Conclusions: Despite a higher proportion of coronary artery disease and a 20% conversion of claudication to critical limb ischemia after failed ET for AIOD, survival was longer in patients undergoing secondary vs primary open surgery. Patients who underwent open surgery after failed ET for AIOD did not require amputation. Failed ET for AIOD does not lead to worse outcomes for patients undergoing open surgery for AIOD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
动脉髂闭塞性疾病血管内治疗失败后开放性手术的疗效分析。
目的:比较主动脉髂闭塞性疾病(AIOD)的首次开放手术与血管内治疗(ET)失败的二次开放手术的疗效。设计:进行回顾性队列研究,分析人口统计学特征、合并症和结果。单位:1998年1月1日至2010年3月31日在附属退伍军人事务医院工作。患者:接受AIOD首次开放手术或AIOD ET失败二次开放手术的患者。主要观察指标:总生存率和肢体保留率。结果:首次开放性手术153例,主动脉股动脉移植67例(43.8%),腋窝股动脉移植38例(24.8%),股股动脉移植48例(31.4%)。二次开放性手术(35例)28例为主动脉股动脉移植(80.0%),5例为腋窝股动脉移植(14.3%),2例为股动脉-股动脉移植(5.7%)。接受原发性和继发性AIOD开放手术的患者的平均5年生存率分别为48.2%(5.6%)和66.8% (10.0%)(P = 0.01)。在平均3年的随访中,有7例截肢,均为首次开放手术组。结论:尽管AIOD ET治疗失败后发生冠状动脉疾病的比例更高,20%的跛行转化为严重肢体缺血,但接受二次开放手术的患者比初次开放手术的患者生存时间更长。在AIOD ET失败后接受开放手术的患者不需要截肢。AIOD的ET失败并不会导致接受AIOD开放手术的患者预后更差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Archives of Surgery
Archives of Surgery 医学-外科
自引率
0.00%
发文量
0
审稿时长
4-8 weeks
期刊最新文献
Synchronous Breast and Thyroid Cancer: Correlation Between two Pathologies and Management Challenges Vascularized Transposition of the Ulnar Nerve in Entrapment Syndrome at the Elbow Pseudohermaphroditism. Brothers. Preoperative biopsy evaluation of chemotherapy-associated liver injuries: looking for a needle in a haystack? Comment on "prospective evaluation of accuracy of liver biopsy findings in the identification of chemotherapy-associated liver injury".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1